The immunohistochemical expression of calcitonin receptor-like receptor (CRLR) in human gliomas

Journal of Clinical Pathology

Volumn 57, Issue 2, 2004, Pages 172-176

  Benes, L ^a   Kappus, C ^a   McGregor, G P ^a   Bertalanffy, H ^a   Mennel, H D ^a   Hagner, S ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; CALCITONIN RECEPTOR LIKE RECEPTOR; PROTEIN ANTIBODY;

ARTICLE; ASTROCYTE; BLOOD VESSEL; BRAIN BIOPSY; BRAIN TISSUE; CANCER GRADING; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROMORPHOLOGY; PRIORITY JOURNAL; PROBABILITY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; TUMOR CELL;

ENDOTHELIUM, VASCULAR; GLIOMA; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CALCITONIN;

EID: 0842308935     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2003.12997     Document Type: Article

References (36)

1. DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114-23.
2. Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996;77:362-72.
3. Plate KH, Mennel HD. Vascular morphology and angiogenesis in glial tumors. Exp Toxicol Pathol 1995;47:89-94.
4. Muff R, Born W, Fischer JA. Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. Eur J Endocrinol 1995;133:17-20.
5. Jougasaki M, Burnett JC Jr. Adrenomedullin: potential in physiology and pathophysiology. Life Sci 2000;66:855-72.
6. Cuttitta F, Pio R, Garayoa M, et al. Adrenomedullin functions as an important tumor survival factor in human carcinogenesis. Microsc Res Tech 2002;57:110-19.
7. Ishikawa T, Chen J, Wang J, et al. Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis. Oncogene 2003;22:1238-42.
8. Shichiri M, Hirata Y. Regulation of cell growth and apoptosis by adrenomedullin. Hypertens Res 2003;26(suppl):S9-14.
9. Juaneda C, Dumont Y, Quirion R. The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends Pharmacol Sci 2000;21:432-8.
10. Born W, Muff R, Fischer JA. Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP). Microsc Res Tech 2002;57:14-22.
11. McLatchie LM, Fraser NJ, Main MJ, et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998;393:333-9.
12. Hagner S, Haberberger R, Kummer W, et al. Immunohistochemical detection of calcitonin gene-related peptide receptor (CGRPR)-1 in the endothelium of human coronary artery and bronchial blood vessels. Neuropeptides 2001;35:58-64.
13. Hagner S, Haberberger RV, Overkamp D, et al. Expression and distribution of calcitonin receptor-like receptor in human hairy skin. Peptides 2002;23:109-16.
14. Hagner S, Stahl U, Knoblauch B, et al. Calcitonin receptor-like receptor: identification and distribution in human peripheral tissues. Cell Tissue Res 2002;310:41-50.
15. Garayoa M, Martinez A, Lee S, et al. Hypoxia-inducible factor-1 (HIF-1) upregulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol Endocrinol 2000;14:848-62.
16. Bratthauer GL. The peroxidase-antiperoxidase (PAP) method. Methods Mol Biol 1994;34:165-73.
17. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61:215-25.
18. Lopez J, Martinez A. Cell and molecular biology of the multifunctional peptide, adrenomedullin. Int Rev Cytol 2002;221:1-92.
19. Franco-Cereceda A, Henke H, Lundberg JM, et al. Calcitonin gene-related peptide (CGRP) in capsaicin-sensitive substance P-immunoreactive sensory neurons in animals and man: distribution and release by capsaicin. Peptides 1987;8:399-410.
20. Ouafik L, Sauze S, Boudouresque F, et al. Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am J Pathol 2002;160:1279-92.
21. Folkman J. Tumor angiogenesis. Adv Cancer Res 1974;19:331-58.
22. Zagzag D, Amirnovin R, Greco MA, et al. Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab Invest 2000;80:837-49.
23. Miyashita K, Itoh H, Sawada N, et al. Adrenomedullin promotes proliferation and migration of cultured endothelial cells. Hypertens Res 2003;26(suppl):S93-8.
24. Haegerstrand A, Dalsgaard CJ, Jonzon B, et al. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci U S A 1990;87:3299-303.
25. Nikitenko LL, Brown NS, Smith DM, et al. Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus. Mol Hum Reprod 2001;7:655-64.
26. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-4.
27. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003;3:401-10.
28. Martinez A, Miller MJ, Unsworth EJ, et al. Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology 1995;136:4099-105.
29. Satoh F, Takahashi K, Murakami O, et al. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytama, ganglioneuroblastoma and neuroblastoma. J Clin Endocrinol Metab 1995;80:1750-2.
30. Zhao Y, Hague S, Manek S, et al. PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium. Oncogene 1998;16:409-15.
31. Miller MJ, Martinez A, Unsworth EJ, et al. Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J Biol Chem 1996;271:23345-51.
32. Fujita Y, Mimata H, Nasu N, et al. Involvement of adrenomedullin induced by hypoxia in angiogenesis in human renal cell carcinoma. Int J Urol 2002;9:285-95.
33. Oehler MK, Norbury C, Hague S, et al. Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth. Oncogene 2001;20:2937-45.
34. Tschopp FA, Tobler PH, Fischer JA. Calcitonin gene-related peptide in the human thyroid, pituitary and brain. Mol Cell Endocrinol 1984;36:53-7.
35. Tschopp FA, Henke H, Petermann JB, et al. Calcitonin gene-related peptide and its binding sites in the human central nervous system and pituitary. Proc Natl Acad Sci U S A 1985;82:248-52.
36. Serrano J, Uttenthal LO, Martinez A, et al. Distribution of adrenomedullin-like immunoreactivity in the rat central nervous system by light and electron microscopy. Brain Res 2000;853:245-68.